These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1548245)

  • 1. Nonsedating treatments for Alzheimer's patients with behavioral problems.
    Hawkins JW
    J Clin Psychiatry; 1992 Mar; 53(3):101-2. PubMed ID: 1548245
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-neuroleptic treatment of behavioral symptoms and agitation in Alzheimer's disease and other dementia.
    Schneider LS; Sobin PB
    Psychopharmacol Bull; 1992; 28(1):71-9. PubMed ID: 1351687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of selegiline in Alzheimer's patients with behavior problems.
    Goad DL; Davis CM; Liem P; Fuselier CC; McCormack JR; Olsen KM
    J Clin Psychiatry; 1991 Aug; 52(8):342-5. PubMed ID: 1907964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selegiline in the treatment of Alzheimer's disease].
    Obenberger J; Roth J
    Cas Lek Cesk; 1995 Jun; 134(12):388-90. PubMed ID: 7553744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of trazodone in Alzheimer's disease.
    Lebert F; Pasquier F; Petit H
    J Clin Psychiatry; 1994 Dec; 55(12):536-8. PubMed ID: 7814348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selegiline and vitamin E in Alzheimer's disease.
    Adelman A
    J Fam Pract; 1997 Aug; 45(2):98-100. PubMed ID: 9267360
    [No Abstract]   [Full Text] [Related]  

  • 7. Noncholinergic treatment options for Alzheimer's disease.
    Sano M
    J Clin Psychiatry; 2003; 64 Suppl 9():23-8. PubMed ID: 12934971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tranylcypromine compared with L-deprenyl in Alzheimer's disease.
    Tariot PN; Sunderland T; Cohen RM; Newhouse PA; Mueller EA; Murphy DL
    J Clin Psychopharmacol; 1988 Feb; 8(1):23-7. PubMed ID: 3127432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the treatment of Alzheimer's disease.
    Schneider LS
    Aging (Milano); 1998 Apr; 10(2):156-7. PubMed ID: 9666210
    [No Abstract]   [Full Text] [Related]  

  • 10. Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.
    Filip V; Kolibás E
    J Psychiatry Neurosci; 1999 May; 24(3):234-43. PubMed ID: 10354658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations].
    Kitamura Y; Kudo Y; Imamura T
    No To Shinkei; 2006 Jun; 58(6):483-8. PubMed ID: 16856516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine in dementia of the Alzheimer's type: prominent adverse effects and failure to improve cognition.
    Geldmacher DS; Waldman AJ; Doty L; Heilman KM
    J Clin Psychiatry; 1994 Apr; 55(4):161. PubMed ID: 8071261
    [No Abstract]   [Full Text] [Related]  

  • 13. Euphoria with buspirone after fluoxetine treatment.
    Lebert F; Pasquier F; Goudemand M; Petit H
    Am J Psychiatry; 1993 Jan; 150(1):167. PubMed ID: 8417565
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluoxetine versus trazodone: efficacy and activating-sedating effects.
    Beasley CM; Dornseif BE; Pultz JA; Bosomworth JC; Sayler ME
    J Clin Psychiatry; 1991 Jul; 52(7):294-9. PubMed ID: 2071559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selegiline in the treatment of mild to moderate Alzheimer-type dementia.
    Monteverde A; Gnemmi P; Rossi F; Monteverde A; Finali GC
    Clin Ther; 1990; 12(4):315-22. PubMed ID: 2121360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selegiline, fluoxetine, and depression in Parkinson's disease.
    Garcia-Monco JC; Padierna A; Gomez Beldarrain M
    Mov Disord; 1995 May; 10(3):352. PubMed ID: 7651457
    [No Abstract]   [Full Text] [Related]  

  • 17. Alpha-tocopherol and Alzheimer's disease.
    Kilander L; Ohrvall M
    N Engl J Med; 1997 Aug; 337(8):572-3. PubMed ID: 9265107
    [No Abstract]   [Full Text] [Related]  

  • 18. Alzheimer's disease management.
    Cummings JL
    J Clin Psychiatry; 1998; 59 Suppl 13():4-5. PubMed ID: 9771824
    [No Abstract]   [Full Text] [Related]  

  • 19. Seizure associated with fluoxetine and adjuvant buspirone therapy.
    Grady TA; Pigott TA; L'Heureux F; Murphy DL
    J Clin Psychopharmacol; 1992 Feb; 12(1):70-1. PubMed ID: 1552045
    [No Abstract]   [Full Text] [Related]  

  • 20. Selegiline versus L-acetylcarnitine in the treatment of Alzheimer-type dementia.
    Campi N; Todeschini GP; Scarzella L
    Clin Ther; 1990; 12(4):306-14. PubMed ID: 2121359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.